How have EPI shares performed in 2024?

ESSA Pharma's stock was trading at C$8.20 on January 1st, 2024. Since then, EPI stock has increased by 0.0% and is now trading at C$8.20. View the best growth stocks for 2024 here .

Is ESSA Pharma a good dividend stock?

ESSA Pharma (CVE:EPI) pays an annual dividend of C$0.22 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of ESSA Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ESSA Pharma investors own include Aurora Cannabis (ACB) , Air Canada (AC) , Arbutus Biopharma (ABUS) , AB Science (ABSCF) , AB International Group (ABQQ) , AB Dynamics (ABDP) , Advantage Energy (AAV) , AA (AATDF) , AAON (AAON) and AAC Technologies (AACAY) .

How do I buy shares of ESSA Pharma?

Shares of EPI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:EPI

ESSA Pharma (EPI) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free EPI Stock Alerts

C$8.20

+0.55 (+7.19%)

(As of 10/30/2020)

Compare

Today's Range: C$7.33
▼
C$8.20
50-Day Range: C$8.20
▼
C$8.20
52-Week Range: C$4.00
▼
C$11.34

Volume: 1,430 shs
Average Volume: 4,834 shs
Market Capitalization: C$237.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get ESSA Pharma alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About ESSA Pharma

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

EPI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

EPI Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive EPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: CVE:EPI
CUSIP: N/A
CIK: N/A
Web: essapharmaceuticals.com
Phone: +1-778-3310962
Fax: N/A
Employees: 25
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 37.29
Quick Ratio: 36.72

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$2.21 per share
Price / Cash Flow: 3.72
Book Value: C$2.21 per share
Price / Book: 3.72

Miscellaneous

Outstanding Shares: 29,009,000
Free Float: N/A
Market Cap: C$237.87 million
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. David Ross Parkinson (Age 71)
Pres, CEO & Director
Comp: $626.81k
Mr. David S. Wood C.M.A. (Age 64)
CPA, M.B.A., MBA, CPA, CMA, Chief Financial Officer
Comp: $311.52k
Mr. Peter A. Virsik M.B.A. (Age 50)
M.S., Exec. VP & COO
Comp: $544.66k
Dr. Alessandra Cesano
Chief Medical Officer
Chandtip Chandhasin
Exec.
Erica Osbourne
Exec.
Erin Rudsinski
Exec.
Leah Dimascio
Exec.
Loleta Harris
Exec.
Neil Thapar
Exec.

Key Competitors

View All Competitors

EPI Stock Analysis - Frequently Asked Questions

How have EPI shares performed in 2024?: ESSA Pharma's stock was trading at C$8.20 on January 1st, 2024. Since then, EPI stock has increased by 0.0% and is now trading at C$8.20.
View the best growth stocks for 2024 here.
Is ESSA Pharma a good dividend stock?: ESSA Pharma (CVE:EPI) pays an annual dividend of C$0.22 per share and currently has a dividend yield of 0.00%.
What other stocks do shareholders of ESSA Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ESSA Pharma investors own include Aurora Cannabis (ACB), Air Canada (AC), Arbutus Biopharma (ABUS), AB Science (ABSCF), AB International Group (ABQQ), AB Dynamics (ABDP), Advantage Energy (AAV), AA (AATDF), AAON (AAON) and AAC Technologies (AACAY).
How do I buy shares of ESSA Pharma?: Shares of EPI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:EPI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial